H. Lee Moffitt Cancer Center & Research Institute H. Lee Moffitt Cancer Ctr (67)
Welcome,         Profile    Billing    Logout  
 6 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pinilla-Ibarz, Javier
NCT03610971: Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors

Recruiting
2
41
US
Ruxolitinib, Jakafi®, BCR-ABL Tyrosine Kinase Inhibitor (TKI), TKI
H. Lee Moffitt Cancer Center and Research Institute, H. Jean Khoury Cure CML Consortium, Incyte Corporation
Chronic Phase Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, Chronic Phase
12/25
12/26
CYTB323A12101, NCT03960840: Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL

Recruiting
1/2
225
Europe, Japan, US, RoW
Rapcabtagene autoleucel single agent, Ibrutinib
Novartis Pharmaceuticals
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia, Large B-cell Lymphoma
06/27
05/28
PLIGHT, NCT06235281: Phototherapy and Mogamulizumab in Early Stage MF

Recruiting
1
20
US
Mogamulizumab-Kpkc, POTELIGEO, Phototherapy, nb-UVB
H. Lee Moffitt Cancer Center and Research Institute, Kyowa Hakko Kirin Pharma, Inc.
Mycosis Fungoides
09/26
09/29
MCC-21622, NCT05694364: Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies

Recruiting
1
88
US
Fludarabine, Fludara, Cyclophosphamide, PRGN-3007
H. Lee Moffitt Cancer Center and Research Institute, Precigen, Inc
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma, Triple Negative Breast Cancer Malignancies
01/26
01/26
C1763102, NCT05602363: AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

Recruiting
1
120
US
Docirbrutinib, AS-1763
Carna Biosciences, Inc.
B-cell Malignancy, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Waldenstrom Macroglobulinemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Follicular Lymphoma, Non-Hodgkin Lymphoma
09/27
09/27
Pinilla-Ibarz, Javier
ENESTFreedom, NCT01784068 / 2012-004092-40: Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients

Active, not recruiting
2
215
Europe, Japan, US, RoW
Nilotinib followed by treatment-free, AMN107
Novartis Pharmaceuticals
Chronic Myelogenous Leukemia
05/16
01/25

Download Options